Related references
Note: Only part of the references are listed.synergy: a Python library for calculating, analyzing and visualizing drug combination synergy
David J. Wooten et al.
BIOINFORMATICS (2021)
Anticancer drug synergy prediction in understudied tissues using transfer learning
Yejin Kim et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2021)
The tumor therapy landscape of synthetic lethality
Biyu Zhang et al.
NATURE COMMUNICATIONS (2021)
The Aurora kinase/β-catenin axis contributes to dexamethasone resistance in leukemia
Kinjal Shah et al.
NPJ PRECISION ONCOLOGY (2021)
An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine
Michelle Whirl-Carrillo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
DrugComb update: a more comprehensive drug sensitivity data repository and analysis portal
Shuyu Zheng et al.
NUCLEIC ACIDS RESEARCH (2021)
PubChem in 2021: new data content and improved web interfaces
Sunghwan Kim et al.
NUCLEIC ACIDS RESEARCH (2021)
Charting the Fragmented Landscape of Drug Synergy
Christian T. Meyer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Resisting antimicrobial resistance
Carl Nathan
NATURE REVIEWS MICROBIOLOGY (2020)
SynergyFinder 2.0: visual analytics of multi-drug combination synergies
Aleksandr Ianevski et al.
NUCLEIC ACIDS RESEARCH (2020)
Machine learning approaches to drug response prediction: challenges and recent progress
George Adam et al.
NPJ PRECISION ONCOLOGY (2020)
Perspective Rational Cancer Treatment Combinations: An Urgent Clinical Need
Julia Boshuizen et al.
MOLECULAR CELL (2020)
Guided screen for synergistic three-drug combinations
Melike Cokol-Cakmak et al.
PLOS ONE (2020)
Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours
Joao M. Fernandes Neto et al.
NATURE COMMUNICATIONS (2020)
Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers
Irem Ozkan-Dagliyan et al.
CELL REPORTS (2020)
Representation of features as images with neighborhood dependencies for compatibility with convolutional neural networks
Omid Bazgir et al.
NATURE COMMUNICATIONS (2020)
Modulation of Triple Artemisinin-Based Combination Therapy Pharmacodynamics by Plasmodium falciparum Genotype
Megan R. Ansbro et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
DrugComb: an integrative cancer drug combination data portal
Bulat Zagidullin et al.
NUCLEIC ACIDS RESEARCH (2019)
Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer
Alina Malyutina et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
Michael P. Menden et al.
NATURE COMMUNICATIONS (2019)
Applying synergy metrics to combination screening data: agreements, disagreements and pitfalls
Anna H. C. Vlot et al.
DRUG DISCOVERY TODAY (2019)
Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma
Joseph J. Caumanns et al.
CANCER LETTERS (2019)
A view on drug resistance in cancer
Neil Vasan et al.
NATURE (2019)
ChEMBL: towards direct deposition of bioassay data
David Mendez et al.
NUCLEIC ACIDS RESEARCH (2019)
Epigenetic therapy in immune-oncology
Peter A. Jones et al.
NATURE REVIEWS CANCER (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Network Propagation Predicts Drug Synergy in Cancers
Hongyang Li et al.
CANCER RESEARCH (2018)
DeepSynergy: predicting anti-cancer drug synergy with Deep Learning
Kristina Preuer et al.
BIOINFORMATICS (2018)
SynergyFinder: a web application for analyzing drug combination dose-response matrix data
Aleksandr Ianevski et al.
BIOINFORMATICS (2017)
ChEBI in 2016: Improved services and an expanding collection of metabolites
Janna Hastings et al.
NUCLEIC ACIDS RESEARCH (2016)
BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology
Michael K. Gilson et al.
NUCLEIC ACIDS RESEARCH (2016)
Combenefit: an interactive platform for the analysis and visualization of drug combinations
Giovanni Y. Di Veroli et al.
BIOINFORMATICS (2016)
An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies
Jennifer O'Neil et al.
MOLECULAR CANCER THERAPEUTICS (2016)
BRAID: A Unifying Paradigm for the Analysis of Combined Drug Action
Nathaniel R. Twarog et al.
SCIENTIFIC REPORTS (2016)
ZINC 15-Ligand Discovery for Everyone
Teague Sterling et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
What is synergy? The Saariselka agreement revisited
Jing Tang et al.
FRONTIERS IN PHARMACOLOGY (2015)
Searching for Drug Synergy in Complex Dose-Response Landscapes Using an Interaction Potency Model
Bhagwan Yadav et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2015)
Mechanism-independent method for predicting response to multidrug combinations in bacteria
Kevin Wood et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
How to obtain the P value from a confidence interval
Douglas G. Altman et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Share Paper
